StockNews.com Begins Coverage on Edap Tms (NASDAQ:EDAP)

Research analysts at StockNews.com began coverage on shares of Edap Tms (NASDAQ:EDAP) in a research note issued on Tuesday. The firm set a “hold” rating on the medical equipment provider’s stock.

Edap Tms Trading Up 0.4 %

Shares of EDAP stock opened at $2.57 on Tuesday. The stock has a market cap of $95.36 million, a price-to-earnings ratio of -3.95 and a beta of 0.36. The stock has a 50-day moving average of $2.39 and a 200-day moving average of $2.66. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. Edap Tms has a 1-year low of $2.00 and a 1-year high of $8.50.

Institutional Investors Weigh In On Edap Tms

Several large investors have recently added to or reduced their stakes in EDAP. BNP Paribas Financial Markets grew its stake in Edap Tms by 23.7% during the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after purchasing an additional 4,400 shares during the period. Parkman Healthcare Partners LLC acquired a new stake in Edap Tms during the third quarter worth approximately $395,000. Orion Capital Management LLC grew its stake in Edap Tms by 10.4% during the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after purchasing an additional 6,600 shares during the period. Illumine Investment Management LLC acquired a new stake in Edap Tms during the fourth quarter worth approximately $50,000. Finally, Rock Springs Capital Management LP grew its stake in Edap Tms by 1.5% during the fourth quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock worth $3,518,000 after purchasing an additional 23,800 shares during the period. Institutional investors and hedge funds own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.